236 related articles for article (PubMed ID: 9257815)
1. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
[TBL] [Abstract][Full Text] [Related]
2. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression.
Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA
Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860
[TBL] [Abstract][Full Text] [Related]
3. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
Chen Z; Li K; Plagemann PG
Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
[TBL] [Abstract][Full Text] [Related]
4. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
6. High-frequency homologous genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants.
Li K; Chen Z; Plagemann P
Virology; 1999 May; 258(1):73-83. PubMed ID: 10329569
[TBL] [Abstract][Full Text] [Related]
7. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
Sasaki Y; Hayashi T; Hasegawa K
Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
[TBL] [Abstract][Full Text] [Related]
8. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
[TBL] [Abstract][Full Text] [Related]
9. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
Cafruny WA; Bradley SE; Rowland RR
Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
Broen JJ; Cafruny WA
Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection.
Even C; Rowland RR; Plagemann PG
J Virol; 1995 Sep; 69(9):5666-76. PubMed ID: 7637013
[TBL] [Abstract][Full Text] [Related]
12. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
Broen JB; Bradley DS; Powell KM; Cafruny WA
Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
[TBL] [Abstract][Full Text] [Related]
13. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection.
Michaelides MC; Simms ES
Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
[TBL] [Abstract][Full Text] [Related]
15. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
Plagemann PG
Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
[TBL] [Abstract][Full Text] [Related]
16. Lactic dehydrogenase virus infection reduces the expulsion of the nematode Nippostrongylus brasiliensis.
Morimoto M; Yamamoto N; Hayashi T
Parasitol Res; 2003 Jun; 90(2):153-6. PubMed ID: 12756552
[TBL] [Abstract][Full Text] [Related]
17. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation.
Bradley DS; Broen JJ; Cafruny WA
Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935
[TBL] [Abstract][Full Text] [Related]
18. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.
Chen Z; Li K; Rowland RR; Plagemann PG
J Neurovirol; 1999 Apr; 5(2):200-8. PubMed ID: 10321985
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation of growth attenuation of murine lymphoma caused by in vitro passage with loss of lactate dehydrogenase virus.
Johnson RJ; Shin HS
J Natl Cancer Inst; 1983 Dec; 71(6):1337-41. PubMed ID: 6581366
[TBL] [Abstract][Full Text] [Related]
20. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease.
Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG
J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]